HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
CERE holding history
Cerevel Therapeutics Holdings, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERE overviewAll 13F holders of CEREFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −500−100.0% | Sold out | Holders |
| Q2 2024 | 500 | $20.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 500 | $21.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 500 | $21.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 500 | $10.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 500 | $15.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 500 | $12.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 500 | $15.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 500 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 500 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 500 | $18.0K | <0.1% | +500 | New | Holders |